Micrel (MCRL)

Add to Watchlists
Create an Alert
10.95 +0.23  +2.10% NASDAQ Apr 22, 8:00PM BATS Real time Currency in USD

Micrel Research and Development Expense (Quarterly):

14.53M for Dec. 31, 2013

View 4,000+ financial data types

View Full Chart

Micrel Research and Development Expense (Quarterly) Chart

Export Data
Save Image

Micrel Historical Research and Development Expense (Quarterly) Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Dec. 31, 2013 14.53M
Sept. 30, 2013 14.06M
June 30, 2013 13.50M
March 31, 2013 13.77M
Dec. 31, 2012 14.60M
Sept. 30, 2012 15.34M
June 30, 2012 13.92M
March 31, 2012 13.32M
Dec. 31, 2011 12.56M
Sept. 30, 2011 12.64M
June 30, 2011 12.23M
March 31, 2011 12.52M
Dec. 31, 2010 11.68M
Sept. 30, 2010 11.68M
June 30, 2010 11.54M
March 31, 2010 11.37M
Dec. 31, 2009 11.14M
Sept. 30, 2009 11.40M
June 30, 2009 11.48M
March 31, 2009 Upgrade
Dec. 31, 2008 Upgrade
Sept. 30, 2008 Upgrade
June 30, 2008 Upgrade
March 31, 2008 Upgrade
Dec. 31, 2007 Upgrade
Sept. 30, 2007 Upgrade
June 30, 2007 Upgrade
March 31, 2007 Upgrade
Dec. 31, 2006 Upgrade
Sept. 30, 2006 Upgrade
June 30, 2006 Upgrade
March 31, 2006 Upgrade
Dec. 31, 2005 Upgrade
Sept. 30, 2005 Upgrade
June 30, 2005 Upgrade
March 31, 2005 Upgrade
Dec. 31, 2004 Upgrade
Sept. 30, 2004 Upgrade
June 30, 2004 Upgrade
March 31, 2004 Upgrade
Dec. 31, 2003 Upgrade
Sept. 30, 2003 Upgrade
June 30, 2003 Upgrade
March 31, 2003 Upgrade
Dec. 31, 2002 Upgrade
Sept. 30, 2002 Upgrade
June 30, 2002 Upgrade
March 31, 2002 Upgrade
Dec. 31, 2001 Upgrade
Sept. 30, 2001 Upgrade

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More

Get data for

MCRL Research and Development Expense (Quarterly) Benchmarks

NeoPhotonics 12.23M
ARM Holdings 88.68M
Advanced Photonix 1.164M

MCRL Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 11.14M Dec 2009
Maximum 15.34M Sep 2012
Average 12.80M

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership


{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.